Patients with active acromegaly are at high risk of 25(OH)D deficiency.

Acromegaly is a chronic disease characterized by hypersecretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Electrolyte disturbances such as hypercalcemia and hyperphosphatemia are reported in patients with this disorder. There is limited data on vitamin D status in subjects wit...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Jowita eHalupczok-Żyła, Aleksandra eJawiarczyk-Przybyłowska, Marek eBolanowski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-06-01
Subjects:	Acromegaly Calcium Vitamin D Phosphate GH IGF-1
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fendo.2015.00089/full

Similar Items

Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
by: Jowita Halupczok-Żyła, et al.
Published: (2024-12-01)

Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in acromegaly patients
by: Małgorzata Rolla, et al.
Published: (2020-12-01)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
by: Aleksandra Jawiarczyk-Przybyłowska, et al.
Published: (2022-04-01)

Risk of intracranial meningioma in patients with acromegaly: a systematic review
by: Amy X. Guo, et al.
Published: (2024-06-01)

Acromegaly without acral anomalies
by: Mara Carsote, et al.
Published: (2021-12-01)

Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study
by: Martina Romanisio, et al.
Published: (2023-09-01)

Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study
by: Małgorzata Rolla, et al.
Published: (2023-04-01)

Acromegaly with initial negative oral glucose tolerance test: a case report
by: Wen-Hsuan Tsai, et al.
Published: (2023-08-01)

The effect of acromegaly on thyroid disease
by: Caiyan Mo, et al.
Published: (2023-11-01)

Serum Phosphorus and Calcium as Biomarkers of Disease Status in Acromegaly
by: Nadia Sawicka-Gutaj, et al.
Published: (2023-12-01)

Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly—A Preliminary Study
by: Martyna Strzelec, et al.
Published: (2025-03-01)

A retrospective multicenter study of pegvisomant use in acromegaly within Russian Federation
by: E. G. Przhyalkovskaya, et al.
Published: (2025-09-01)

Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
by: Marek Bolanowski, et al.
Published: (2022-02-01)

Somatic GNAS mutations in acromegaly: prevalence, clinical features and gender differences
by: Yamei Yang, et al.
Published: (2024-12-01)

Therapeutic effect of presurgical treatment with longacting octreotide (Sandostatin® LAR®) in patients with acromegaly
by: Marek Bolanowski, et al.
Published: (2020-08-01)

Pituitary Disorders and Osteoporosis
by: Marek Bolanowski, et al.
Published: (2015-01-01)

The state of Sergipe contribution to GH research: from Souza Leite to Itabaianinha syndrome
by: Manuel H. Aguiar-Oliveira, et al.
Published: (2022-11-01)

Acromegaly and hypertension
by: WANG Shu-chang, ZHU Hui-juan, PAN Hui
Published: (2021-09-01)

Preoperative and postoperative blood testosterone levels in patients with acromegaly: a prospective study
by: Duoxing Zhang, et al.
Published: (2023-10-01)

Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice
by: Kohei Oguni, et al.
Published: (2024-03-01)

Comparison of the clinical and prognostic characteristics of patients with different pathological types in acromegaly
by: Liye Chong, et al.
Published: (2025-05-01)

Allostatic load index in patients with pituitary tumours: a case control study
by: Martyna Strzelec, et al.
Published: (2025-10-01)

Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences
by: Sabrina Chiloiro, et al.
Published: (2024-05-01)

Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs
by: Charles P. Daniel, et al.
Published: (2023-09-01)

Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
by: David R. Clemmons, et al.
Published: (2023-10-01)

Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal
by: Przemysław Witek, et al.
Published: (2024-12-01)

Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study
by: Christian Rosendal, et al.
Published: (2024-04-01)

Duhok acromegaly; a prospective cohort study
by: Bayar Ahmed Qasim
Published: (2023-03-01)

Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
by: Kristin Godang, et al.
Published: (2019-12-01)

Prevalence of acromegaly and clinical guidelines
by: V. S. Pronin, et al.
Published: (2014-12-01)

Ectopic Acromegaly Secondary to Bronchial Tumor; a Case Report of Rare Occurrence.
by: Sara Sohail, et al.
Published: (2021-01-01)

Quality of life in patients with acromegaly receiving lanreotide autogel: a real-world observational study
by: Marek Bolanowski, et al.
Published: (2021-10-01)

Secondary erythrocytosis in patient with acromegaly
Published: (2011-12-01)

Is circulating survivin altered in acromegaly?
by: Esra Ademoglu, et al.
Published: (2018-06-01)

Improvement of acromegaly control with multimodal therapy in Romania
by: Mihai C. Marinescu, et al.
Published: (2020-06-01)

The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly
by: Mustafa Demirpençe, et al.
Published: (2020-01-01)

Pasireotide: A new option for treatment of acromegaly
by: Filiz Eksi Haydardedeoglu, et al.
Published: (2020-06-01)

Therapeutic Targeting of the IGF Axis
by: Eliot Osher, et al.
Published: (2019-08-01)

Differential Diagnosis of Acromegaly: Pachydermoperiostosis Two New Cases from Turkey
by: Emine Kartal Baykan, et al.
Published: (2022-09-01)

Modern methods of medical treatment of acromegaly
by: V. S. Pronin, et al.
Published: (2020-01-01)